Alere, InDevR Win BARDA Contracts To Develop Rapid Influenza Tests
This article was originally published in The Gray Sheet
Two rapid test manufacturers, Alere and InDevR, win multi-million dollar, multiple-year contracts with HHS’s Biomedical Advanced Research and Development Authority to develop point-of-care diagnostics to swiftly identify pandemic influenza strains from nasal samples.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.